30 related articles for article (PubMed ID: 17004718)
1. Electrochemical Synthesis of New Isoxazoles and Triazoles Tethered with Thiouracil Base as Inhibitors of Histone Deacetylases in Human Breast Cancer Cells.
Vishwanath D; Xi Z; Ravish A; Mohan A; Basappa S; Krishnamurthy NP; Gaonkar SL; Pandey V; Lobie PE; Basappa B
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446915
[TBL] [Abstract][Full Text] [Related]
2. Effects of Structurally Different HDAC Inhibitors against
Di Bello E; Noce B; Fioravanti R; Zwergel C; Valente S; Rotili D; Fianco G; Trisciuoglio D; Mourão MM; Sales P; Lamotte S; Prina E; Späth GF; Häberli C; Keiser J; Mai A
ACS Infect Dis; 2022 Jul; 8(7):1356-1366. PubMed ID: 35732073
[TBL] [Abstract][Full Text] [Related]
3. Histone Deacetylase Inhibitors: A Prospect in Drug Discovery.
Yadav R; Mishra P; Yadav D
Turk J Pharm Sci; 2019 Mar; 16(1):101-114. PubMed ID: 32454703
[TBL] [Abstract][Full Text] [Related]
4. Single-Step Enrichment of a TAP-Tagged Histone Deacetylase of the Filamentous Fungus Aspergillus nidulans for Enzymatic Activity Assay.
Bauer I; Pidroni A; Bayram Ö; Brosch G; Graessle S
J Vis Exp; 2019 May; (147):. PubMed ID: 31107465
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
[TBL] [Abstract][Full Text] [Related]
6. Tumour-specific metabolic adaptation to acidosis is coupled to epigenetic stability in osteosarcoma cells.
Chano T; Avnet S; Kusuzaki K; Bonuccelli G; Sonveaux P; Rotili D; Mai A; Baldini N
Am J Cancer Res; 2016; 6(4):859-75. PubMed ID: 27186436
[TBL] [Abstract][Full Text] [Related]
7. Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells.
Varricchio L; Dell'Aversana C; Nebbioso A; Migliaccio G; Altucci L; Mai A; Grazzini G; Bieker JJ; Migliaccio AR
Int J Biochem Cell Biol; 2014 May; 50():112-22. PubMed ID: 24594363
[TBL] [Abstract][Full Text] [Related]
8. Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines.
Bontempo P; Rigano D; Doto A; Formisano C; Conte M; Nebbioso A; Carafa V; Caserta G; Sica V; Molinari AM; Altucci L
Cell Prolif; 2013 Apr; 46(2):183-92. PubMed ID: 23510473
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue.
Galmozzi A; Mitro N; Ferrari A; Gers E; Gilardi F; Godio C; Cermenati G; Gualerzi A; Donetti E; Rotili D; Valente S; Guerrini U; Caruso D; Mai A; Saez E; De Fabiani E; Crestani M
Diabetes; 2013 Mar; 62(3):732-42. PubMed ID: 23069623
[TBL] [Abstract][Full Text] [Related]
10. Psidium guajava L. anti-neoplastic effects: induction of apoptosis and cell differentiation.
Bontempo P; Doto A; Miceli M; Mita L; Benedetti R; Nebbioso A; Veglione M; Rigano D; Cioffi M; Sica V; Molinari AM; Altucci L
Cell Prolif; 2012 Feb; 45(1):22-31. PubMed ID: 22172154
[TBL] [Abstract][Full Text] [Related]
11. Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.
Cheng D; Valente S; Castellano S; Sbardella G; Di Santo R; Costi R; Bedford MT; Mai A
J Med Chem; 2011 Jul; 54(13):4928-32. PubMed ID: 21612300
[TBL] [Abstract][Full Text] [Related]
12. Emerging trends in metalloprotein inhibition.
Rouffet M; Cohen SM
Dalton Trans; 2011 Apr; 40(14):3445-54. PubMed ID: 21290034
[TBL] [Abstract][Full Text] [Related]
13. Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity.
Mai A; Valente S; Rotili D; Massa S; Botta G; Brosch G; Miceli M; Nebbioso A; Altucci L
Int J Biochem Cell Biol; 2007; 39(7-8):1510-22. PubMed ID: 17482499
[TBL] [Abstract][Full Text] [Related]
14. Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates.
Mai A; Massa S; Rotili D; Pezzi R; Bottoni P; Scatena R; Meraner J; Brosch G
Bioorg Med Chem Lett; 2005 Nov; 15(21):4656-61. PubMed ID: 16165353
[TBL] [Abstract][Full Text] [Related]
15. 2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.
Mahboobi S; Sellmer A; Höcher H; Garhammer C; Pongratz H; Maier T; Ciossek T; Beckers T
J Med Chem; 2007 Sep; 50(18):4405-18. PubMed ID: 17691763
[TBL] [Abstract][Full Text] [Related]
16. Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation.
Bouchain G; Delorme D
Curr Med Chem; 2003 Nov; 10(22):2359-72. PubMed ID: 14529479
[TBL] [Abstract][Full Text] [Related]
17. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy?
Taddei A; Roche D; Bickmore WA; Almouzni G
EMBO Rep; 2005 Jun; 6(6):520-4. PubMed ID: 15940285
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.
Mai A; Massa S; Rotili D; Simeoni S; Ragno R; Botta G; Nebbioso A; Miceli M; Altucci L; Brosch G
J Med Chem; 2006 Oct; 49(20):6046-56. PubMed ID: 17004718
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
